The (un)fair allocation of scarce vaccines and how math can provide a solution

Research scientist with gloves holding blood sample on glass in laboratory. Biology doctor analyzing plasma dna for medical discovery in pharmaceutical industry. Science equipment on desk

Remember when COVID-19 vaccines first became available? After many months of lockdowns and increasing casualty rates, people across the planet were allowed to exhale a collective sigh of relief. However, as is always the case when new vaccines are developed, there were not enough doses for all who wanted them. Rationing had to be imposed.

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Previous article

New look at an ancient disease: Study finds novel treatment targets for gout

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations